Diana L. Thomas
Affiliations: | 2010 | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Google:
"Diana Thomas"Mean distance: 15.82 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Edward J. Roy | grad student | 2010 | UIUC | |
| (Evaluation of adoptive T cell therapy and oncolytic virotherapy for treatment of brain tumors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Canella A, Nazzaro M, Rajendran S, et al. (2023) Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment. Cell Reports. 42: 112891 |
| Tang B, Guo ZS, Bartlett DL, et al. (2020) Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Misiolek KA, Osborn ZG, Hauser N, et al. (2019) Rapidly growing, multifocal, benign choroid plexus tumor in an infant: case report. Journal of Neurosurgery. Pediatrics. 1-6 |
| Thomas DL, Manners J, Marker D, et al. (2017) CD8-Positive T-Cell Leukoencephalitis With Astrocytopathy Clinically Presenting as Neuromyelitis Optica. Journal of Neuropathology and Experimental Neurology |
| Tosic V, Thomas DL, Kranz DM, et al. (2014) Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity. Plos One. 9: e109801 |
| Tosic V, Thomas DL, Kranz DM, et al. (2013) Interleukin-15 (IL-15) and IL-15 receptor alpha fusion protein enhances antitumor activity of myxoma virus Journal For Immunotherapy of Cancer. 1 |
| West DC, Qin Y, Peterson QP, et al. (2012) Differential effects of procaspase-3 activating compounds in the induction of cancer cell death. Molecular Pharmaceutics. 9: 1425-34 |
| Thomas DL, Doty R, Tosic V, et al. (2011) Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors. Cancer Immunology, Immunotherapy : Cii. 60: 1461-72 |
| France MR, Thomas DL, Liu J, et al. (2011) Intraventricular injection of myxoma virus results in transient expression of viral protein in mouse brain ependymal and subventricular cells. The Journal of General Virology. 92: 195-9 |
| Thomas DL, Kim M, Bowerman NA, et al. (2009) Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 1828-37 |